May 02, 2012, 07.05 PM | Source: CNBC-TV18
D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon.
Sharma told CNBC-Awaaz, "One can accumulate Biocon with a stoploss of Rs 229. The stock can touch level of Rs 255 in medium term."
The company touched its 52-week high Rs 382.00 and 52-week low Rs 225.75 on 20 Jul, 2011 and 27 Apr, 2012, respectively.
Currently, it is trading -37.72% below its 52-week high and 5.38% above its 52-week low.
The Delhi High Court today told Swiss pharma major
Biocon shares gained 2.6 percent to hit a record h
Biocon Thursday announced the US Food and Drug Adm
eLAJ clinics are technology-enabled,smart clinics
The pharmaceutical industry was expecting some fis